… In addition, in the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic
Events in Atrial Fibrillation) study evaluating apixaban versus warfarin, diabetes was found …

… Apixaban is a selective and reversible coagulation factor Xa inhibitor that indirectly inhibits
… risk in patients with atrial fibrillation. The Europe guideline for apixaban utilization in 2013 …

… blood coagulation factor X inhibitors (rivaroxaban, apixaban, edoxaban) have been used
as the preferred initial anticoagulant therapy for atrial fibrillation in recent years. In this article …

… In atrial fibrillation with moderate to severe renal impairment, there was no significant … in
addition to apixaban. We suggest that patient with high bleeding risk may select apixaban. It was …

… and apixaban levels in asian patients with atrial fibrillation. … We further enrolled patients
under rivaroxaban or apixaban … trials, in comparison to apixaban concentration. In addition, low …

… varoxaban,apixaban,etc,may change the current status of … AVERROES:apixaban ve瞄u8
acetylsalicylic acid to prevent … atrial fibrillation patients who have failed Or a∞unsuitable for …

目的: 评估与维生素K 口服抗凝剂(VKA) 相比, 在心房颤动(房颤) 合并透析患者中使用利伐沙班或
阿哌沙班抗凝的有效性和安全性. 方法: 计算机检索PubMed, Embase, CochraneLibrary, 中国…

誤: 8) Lee S, Monz BU, Clemens A, Brueckmann M, Lip GYH, Representativeness of the
dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation …

… Apixaban在預防缺血性腦中風也未觀察到統計上的差異. 結論台灣臨床上dabigatran和rivaroxaban的
使用,多以低劑量為主,Apixaban則以… Background Atrial fibrillation (AF) patients have a …

… We further ranked the NOACs for the lowest risk of GIB (apixaban 5 mg) and ICH (apixaban
5 mg, dabigatran 110 mg, and edoxaban 30 mg). Conclusions: Bayesian network meta-…